Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Headquartered in San Antonio, Texas, USA, Kinetic Concepts Inc (KCI) is a medical technology company which develops, manufactures and sells advanced wound care products and therapeutic surfaces. The company is the global market leader for advanced wound care systems, and its products in this area incorporate its proprietary Vacuum Assisted Closure (V.A.C.) technology, designed to promote wound healing and reduce the cost of treating patients with serious wounds.

KCI's therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility, prevent skin breakdown and assist caregivers in handling obese patients. The company's other products include systems designed to prevent deep vein thrombosis and venous stasis, enhance arterial circulation and assist with the healing of cutaneous ulceration in the lower extremities.

The company has a workforce of over 5,700 people, including a salesforce of approximately 1,630 individuals, of which around 485 have clinical backgrounds. The majority of its manufacturing and R&D takes place in San Antonio, and KCI also has smaller manufacturing bases in Belgium and the UK.

Over the last several years, KCI's growth has been driven primarily by increased demand for its V.A.C. products, which accounted for approximately 75% of the company's total revenue in fiscal 2005, up from 70% in 2004. Much of the revenue generated by the company is derived from product rentals, which accounted for 71% of total sales in fiscal 2005. In addition, most revenue came from the company's US operations, which accounted for 73% of the total in 2005, helped by strong physician awareness of KCI's V.A.C. technology and the company's purchasing contracts with large US GPOs such as Novation. The historic growth has also been driven by a reimbursement code assigned to V.A.C. systems and disposables by the US Centers for Medicare and Medicaid Services. Until recently, the company was the only one to offer products under this code, but now products marketed by BlueSky Medical have also been assigned to the same codes.